Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDB1- and CUL4-associated factor 5 (DCAF5) is a substrate receptor protein for the CUL4-DDB1 E3 ubiquitin ligase complex[2][6]. It contains WD repeat domains and mediates ubiquitination and degradation of specific protein substrates, including incompletely assembled SWI/SNF chromatin remodeling complexes in the absence of SMARCB1[1][4][2]. DCAF5 is essential for the survival of SMARCB1-mutant cancer cells because it clears defective SWI/SNF complexes, a process critical to the oncogenic state in these cancers. Loss or inhibition of DCAF5 in SMARCB1-deficient cells leads to reaccumulation of functional chromatin remodeling complexes and reversal of malignancy phenotypes[1][4]. DCAF5 also plays roles in developmental regulation and cellular homeostasis, with genomic deletion associated with neurodevelopmental phenotypes[2][5][7]. Its WD repeat domain structure provides a potential druggable site, but clinical inhibitors or drugs directly targeting DCAF5 are not yet established[4].
Targeting DCAF5 inhibits its E3 ligase function, stabilizes partially assembled SWI/SNF complexes, and restores chromatin remodeling activity in SMARCB1-mutant cancers[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDB1- and CUL4-associated factor 5 (DCAF5).